F.L. Putnam Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Buy |
99,473
+95,234
| +2,247% | +$10.2M | 0.18% | 110 |
|
|
2025
Q1 | $428K | Hold |
4,239
| – | – | 0.01% | 439 |
|
|
2024
Q4 | $379K | Buy |
4,239
+1
| +0% | +$89 | 0.01% | 459 |
|
|
2024
Q3 | $355K | Sell |
4,238
-2,405
| -36% | -$202K | 0.01% | 476 |
|
|
2024
Q2 | $512K | Sell |
6,643
-1,004
| -13% | -$77.3K | 0.01% | 411 |
|
|
2024
Q1 | $524K | Sell |
7,647
-2,016
| -21% | -$138K | 0.01% | 338 |
|
|
2023
Q4 | $559K | Buy |
9,663
+2,806
| +41% | +$162K | 0.01% | 320 |
|
|
2023
Q3 | $362K | Sell |
6,857
-646
| -9% | -$34.1K | 0.01% | 384 |
|
|
2023
Q2 | $406K | Buy |
7,503
+1,200
| +19% | +$64.9K | 0.01% | 379 |
|
|
2023
Q1 | $315K | Buy |
6,303
+1,030
| +20% | +$51.5K | 0.01% | 355 |
|
|
2022
Q4 | $244K | Buy |
+5,273
| New | +$244K | 0.01% | 373 |
|
|
2022
Q2 | – | Sell |
-5,336
| Closed | -$236K | – | 404 |
|
|
2022
Q1 | $236K | Buy |
5,336
+266
| +5% | +$11.8K | 0.01% | 376 |
|
|
2021
Q4 | $215K | Sell |
5,070
-409
| -7% | -$17.3K | 0.01% | 388 |
|
|
2021
Q3 | $238K | Buy |
5,479
+319
| +6% | +$13.9K | 0.01% | 372 |
|
|
2021
Q2 | $221K | Buy |
+5,160
| New | +$221K | 0.01% | 385 |
|